Beta Lifescience
- Home
- Companies
- Beta Lifescience
- Products
- Beta Lifescience - Model BLSN-013M - ...
Beta Lifescience - Model BLSN-013M - Anti-2019-nCoV NP mAb (IgG&IgM Positive Control)
FromBeta Lifescience
The Anti SARS-COV2 / 2019-nCoV NP mAb (IgG&IgM Positive Control) product contains two isotype antibody clone Human IgG and IgM, which can recognizes2019-nCoV Nucleocapsid Protein.
Most popular related searches
in vitro diagnostic use
clinical chemistry
respiratory disease
immunoassay system
clinical chemistry system
coronavirus
immunoassay
- Host Species: 2019-nCoV
- Background: 2019 Novel Coronavirus (2019-nCoV) is a virus (more specifically, a coronavirus) identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China.
- Source: Vitro
- Formulation: This product contains anti-2019-nCoV NP Antibody(Human IgG Clone#6G9) 1ml and anti-2019-nCoV NP Antibody(Human IgM Clone#4G8) 1ml
- Usage: Anti-2019-nCoV NP mAb (IgG&IgM Positive Control) is intended for in vitro diagnostic use in the quality control of serum on clinical chemistry and immunoassay systems. The assayed liquid protein controls are for the control of accuracy.
- Storage: Store at 4°C if entire vial will be used within 1 month. Store, frozen at -20°C for longer periods of time. Avoid repeated freeze-thaw cycles.